Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS Factor MSCI USA Quality Screened UCITS ETF hEUR acc
IE00BWT3KN65 · IE00BWT3KN65 · EUR · domicile Ireland
Equity · United States · QualityEUR-hedged share classSFDR art. 8
Index tracked: MSCI USA Quality Advanced Target Select 100% Hedged to EUR Index (Net Total Return)
- TER
- 0.28%+ trans. 0.00%
- Fund size
- 65 m EUR
- Tracking difference
- −0.11%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (full replication)
- Income
- Accumulating
Launch 10 Dec 2015 · costs from the KID as of 2 Sept 2026 · 100 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and will take proportionate exposure on the components of the MSCI USA Quality Advanced Target Select 100% Hedged to EUR Index (Net Total Return) either through direct investments in all or substantially all of the component securities and/or through the use of derivatives in particular where it may not be possible or practicable to replicate the index through direct investments or in order to generate efficiencies in gaining exposure to the index. There may also be instances where a sub-fund holds securities which are not…
Performance since series start (in euro) — base 100
10 Dec 2015 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +21.2% |
| 3 years | +64.7% |
| 5 years | +55.8% |
| 10 years | +253.9% |
| Since series start | +266.6% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 14.86% | 16.77% | 19.12% |
| Max drawdown | −12.01% | −21.44% | −32.31% |
| Sharpe | 1.22 | 0.89 | 0.44 |
| Sortino | 1.78 | 1.31 | 0.63 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BWT3KN65 · IE00BWT3KN651
RebalixIE00BWT3KN65 · IE00BWT3KN65 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +15.25% | +15.39% | −0.14% |
| 2024 | +18.61% | +18.72% | −0.11% |
| 2023 | +31.72% | +31.79% | −0.07% |
| 2022 | −25.49% | −25.45% | −0.05% |
| 2021 | +25.84% | +26.07% | −0.23% |
Holdings
Portfolio as declared by the issuer · 19 Aug 2026 · 100 securities · top-10 weight = 45.1%
| Top holdings | Weight |
|---|---|
| 9.0% | |
| 8.6% | |
| 7.0% | |
| 3.8% | |
| 3.0% | |
| 2.9% | |
| 2.8% | |
| 2.8% | |
| 2.7% | |
| 2.6% |
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
UQLTE · Borsa Italiana (ETFplus)
UBUX · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · www.ubs.com/2/e/files/ubs_irl_etf_plc_peit.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BWT3KN65
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BWT3KN65
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BWT3KN65 · IE00BWT3KN652